Hartmut Halfter

2.3k total citations
36 papers, 1.7k citations indexed

About

Hartmut Halfter is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hartmut Halfter has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hartmut Halfter's work include Cytokine Signaling Pathways and Interactions (10 papers), Hereditary Neurological Disorders (7 papers) and interferon and immune responses (6 papers). Hartmut Halfter is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Hereditary Neurological Disorders (7 papers) and interferon and immune responses (6 papers). Hartmut Halfter collaborates with scholars based in Germany, United States and Switzerland. Hartmut Halfter's co-authors include Peter Young, Dieter Gallwitz, Hubert Serve, Carsten Müller‐Tidow, Wolfgang E. Berdel, Thomas Büchner, Florian Stögbauer, S Serve, Masao Mizuki and R. Fenski and has published in prestigious journals such as Nucleic Acids Research, Journal of Neuroscience and The EMBO Journal.

In The Last Decade

Hartmut Halfter

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hartmut Halfter Germany 23 886 430 377 255 245 36 1.7k
Atsunori Saraya Japan 25 1.6k 1.8× 473 1.1× 256 0.7× 112 0.4× 136 0.6× 47 2.3k
Dalia Goldenberg Israel 17 1.2k 1.3× 396 0.9× 291 0.8× 294 1.2× 63 0.3× 21 2.2k
Elena Sokolova Russia 25 983 1.1× 183 0.4× 156 0.4× 277 1.1× 66 0.3× 40 1.6k
Claus Liebmann Germany 21 952 1.1× 137 0.3× 288 0.8× 300 1.2× 389 1.6× 62 1.5k
Stephen P. Trusko United States 17 1.2k 1.4× 88 0.2× 630 1.7× 261 1.0× 140 0.6× 22 2.1k
Sylvie Cazaubon France 22 1.2k 1.3× 95 0.2× 283 0.8× 261 1.0× 120 0.5× 35 2.3k
Frank Schnütgen Germany 20 1.4k 1.6× 164 0.4× 140 0.4× 324 1.3× 74 0.3× 50 1.9k
Florence Botteri Switzerland 17 836 0.9× 118 0.3× 160 0.4× 488 1.9× 88 0.4× 26 2.0k
Alexander K. Ebralidze United States 19 1.6k 1.8× 292 0.7× 156 0.4× 140 0.5× 68 0.3× 25 1.9k
José L. Zugaza Spain 25 1.3k 1.5× 83 0.2× 252 0.7× 359 1.4× 154 0.6× 49 2.3k

Countries citing papers authored by Hartmut Halfter

Since Specialization
Citations

This map shows the geographic impact of Hartmut Halfter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Halfter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Halfter more than expected).

Fields of papers citing papers by Hartmut Halfter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartmut Halfter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Halfter. The network helps show where Hartmut Halfter may publish in the future.

Co-authorship network of co-authors of Hartmut Halfter

This figure shows the co-authorship network connecting the top 25 collaborators of Hartmut Halfter. A scholar is included among the top collaborators of Hartmut Halfter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartmut Halfter. Hartmut Halfter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halfter, Hartmut, et al.. (2018). Idiopathic Hypersomnia Patients Revealed Longer Circadian Period Length in Peripheral Skin Fibroblasts. Frontiers in Neurology. 9. 424–424. 33 indexed citations
2.
Niemann, Axel, Nina Huber, Christian Somandin, et al.. (2014). The Gdap1 knockout mouse mechanistically links redox control to Charcot–Marie–Tooth disease. Brain. 137(3). 668–682. 58 indexed citations
3.
Gess, Burkhard, et al.. (2014). Desmoplakin is involved in organization of an adhesion complex in peripheral nerve regeneration after injury. Experimental Neurology. 264. 55–66. 5 indexed citations
4.
Gess, Burkhard, Robert Fledrich, Michael W. Sereda, et al.. (2011). Sodium-Dependent Vitamin C Transporter 2 Deficiency Causes Hypomyelination and Extracellular Matrix Defects in the Peripheral Nervous System. Journal of Neuroscience. 31(47). 17180–17192. 36 indexed citations
5.
Appenzeller, Silke, Anja Schirmacher, Hartmut Halfter, et al.. (2010). Autosomal-Dominant Striatal Degeneration Is Caused by a Mutation in the Phosphodiesterase 8B Gene. The American Journal of Human Genetics. 86(1). 83–87. 23 indexed citations
6.
Khazaei, Mohammad Rasool, et al.. (2010). Bex1 is involved in the regeneration of axons after injury. Journal of Neurochemistry. 115(4). 910–920. 30 indexed citations
7.
Gess, Burkhard, et al.. (2009). Sodium‐dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L‐ascorbic acid into Schwann cells. Glia. 58(3). 287–299. 41 indexed citations
8.
9.
Vogel, Wolfgang F., et al.. (2002). Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. Glycobiology. 12(8). 517–522. 3 indexed citations
10.
Friedrich, Matthias, Florian Stögbauer, Volker Senner, et al.. (2001). Complete inhibition of in vivo glioma growth by oncostatin M. Journal of Neurochemistry. 76(5). 1589–1592. 23 indexed citations
11.
Kopka, Klaus, Burkhard Riemann, Matthias Friedrich, et al.. (2001). Characterization of 3‐[123I]iodo‐L‐α‐methyl tyrosine transport in astrocytes of neonatal rats. Journal of Neurochemistry. 76(1). 97–104. 10 indexed citations
12.
Young, Peter, Korbinian Grote, Otfried Debus, et al.. (2001). Mutation analysis in Charcot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity. Journal of Neurology. 248(5). 410–415. 26 indexed citations
13.
Halfter, Hartmut, et al.. (2000). Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells. Molecular Brain Research. 80(2). 198–206. 8 indexed citations
14.
Roeb, Elke, et al.. (2000). Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate. Cancer Letters. 149(1-2). 163–170. 13 indexed citations
15.
Halfter, Hartmut, et al.. (1999). Activation of Jak-Stat and MAPK2 Pathways by Oncostatin M Leads to Growth Inhibition of Human Glioma Cells. PubMed. 1(2). 109–116. 20 indexed citations
16.
Riemann, Burkhard, Florian Stögbauer, Klaus Kopka, et al.. (1999). Kinetics of 3-[123I]iodo-l-α-methyltyrosine transport in rat C6 glioma cells. PubMed. 26(10). 1274–1278. 24 indexed citations
17.
Weis, Joachim, Stephan Züchner, D. Chichung Lie, et al.. (1999). CNTF and its Receptor Subunits in Human Gliomas. Journal of Neuro-Oncology. 44(3). 243–253. 22 indexed citations
18.
Halfter, Hartmut, Ramin Lotfi, Reiner Westermann, et al.. (1998). Inhibition of Growth and Induction of Differentiation of Glioma Cell Lines by Oncostatin M (OSM). Growth Factors. 15(2). 135–147. 40 indexed citations
19.
Halfter, Hartmut, Joachim Kremerskothen, U. Hacker-Klom, et al.. (1998). Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor. Journal of Neuro-Oncology. 39(1). 1–18. 31 indexed citations
20.
Halfter, Hartmut & Dieter Gallwitz. (1988). Impairment of yeast pre-mRNA splicing by potential secondary structure-forming sequences near the conserved branchpoint sequence. Nucleic Acids Research. 16(22). 10413–10423. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsunori Saraya Breakdown of academic impact, for papers by Dalia Goldenberg Breakdown of academic impact, for papers by Elena Sokolova Breakdown of academic impact, for papers by Claus Liebmann Breakdown of academic impact, for papers by Stephen P. Trusko Breakdown of academic impact, for papers by Sylvie Cazaubon Breakdown of academic impact, for papers by Frank Schnütgen Breakdown of academic impact, for papers by Florence Botteri Breakdown of academic impact, for papers by Alexander K. Ebralidze Breakdown of academic impact, for papers by José L. Zugaza
Rankless by CCL
2026